Thermo Fisher Ownership
| TMO Stock | USD 408.28 3.84 0.93% |
Shares in Circulation | First Issued 1985-09-30 | Previous Quarter 383 M | Current Value 379 M | Avarage Shares Outstanding 253.1 M | Quarterly Volatility 142.6 M |
Thermo Stock Ownership Analysis
About 93.0% of the company shares are owned by institutional investors. The book value of Thermo Fisher was at this time reported as 130.84. The company has Price/Earnings To Growth (PEG) ratio of 1.57. Thermo Fisher Scientific recorded earning per share (EPS) of 17.07. The entity last dividend was issued on the 13th of June 2025. The firm had 3:2 split on the 6th of June 1996. Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company was incorporated in 1956 and is based in Waltham, Massachusetts. Thermo Fisher operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 130000 people. To find out more about Thermo Fisher Scientific contact Marc Casper at 781 622 1000 or learn more at https://www.thermofisher.com.Besides selling stocks to institutional investors, Thermo Fisher also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Thermo Fisher's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Thermo Fisher's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Thermo Fisher Quarterly Liabilities And Stockholders Equity |
|
Thermo Fisher Insider Trades History
Less than 1% of Thermo Fisher Scientific are currently held by insiders. Unlike Thermo Fisher's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Thermo Fisher's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Thermo Fisher's insider trades
Thermo Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Thermo Fisher is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Thermo Fisher Scientific backward and forwards among themselves. Thermo Fisher's institutional investor refers to the entity that pools money to purchase Thermo Fisher's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Franklin Resources Inc | 2025-03-31 | 4.4 M | Bank Of America Corp | 2025-03-31 | 4 M | Northern Trust Corp | 2025-03-31 | 3.9 M | Royal Bank Of Canada | 2025-03-31 | 3.2 M | Amundi | 2025-03-31 | 3 M | Charles Schwab Investment Management Inc | 2025-03-31 | 2.9 M | Pictet Asset Manangement Sa | 2025-03-31 | 2.9 M | Ubs Asset Mgmt Americas Inc | 2025-03-31 | 2.8 M | Fisher Asset Management, Llc | 2025-03-31 | 2.7 M | Vanguard Group Inc | 2025-03-31 | 33.5 M | Blackrock Inc | 2025-03-31 | 29.1 M |
Thermo Fisher Scientific Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Thermo Fisher insiders, such as employees or executives, is commonly permitted as long as it does not rely on Thermo Fisher's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Thermo Fisher insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Scott Sperling over six months ago Acquisition by Scott Sperling of tradable shares of Thermo Fisher subject to Rule 16b-3 | ||
Marc Casper over a year ago Disposition of 610 shares by Marc Casper of Thermo Fisher at 578.3 subject to Rule 16b-3 | ||
Joseph Holmes over a year ago Disposition of tradable shares by Joseph Holmes of Thermo Fisher at 593.03 subject to Rule 16b-3 | ||
Peter Wilver over a year ago Acquisition by Peter Wilver of 27000 shares of Thermo Fisher subject to Rule 16b-3 |
Thermo Fisher's latest congressional trading
Congressional trading in companies like Thermo Fisher Scientific, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Thermo Fisher by those in governmental positions are based on the same information available to the general public.
| 2025-06-19 | Representative Richard W Allen | Acquired $15K to $50K | Verify | ||
| 2025-06-18 | Representative Thomas H Kean | Acquired Under $15K | Verify | ||
| 2025-06-11 | Senator Markwayne Mullin | Acquired $15K to $50K | Verify | ||
| 2025-06-10 | Senator Markwayne Mullin | Acquired $15K to $50K | Verify | ||
| 2025-05-19 | Representative Dan Newhouse | Acquired Under $15K | Verify | ||
| 2025-05-16 | Representative Richard W Allen | Acquired $15K to $50K | Verify | ||
| 2025-05-13 | Representative Bruce Westerman | Acquired Under $15K | Verify | ||
| 2025-05-12 | Senator Markwayne Mullin | Acquired $50K to $100K | Verify | ||
| 2025-05-11 | Senator Markwayne Mullin | Acquired $50K to $100K | Verify | ||
| 2025-04-29 | Representative Rob Bresnahan | Acquired $15K to $50K | Verify | ||
| 2025-04-09 | Representative Greg Landsman | Acquired Under $15K | Verify | ||
| 2023-10-11 | Senator Markwayne Mullin | Acquired $15K to $50K | Verify | ||
| 2023-09-17 | Senator Dan Sullivan | Acquired Under $15K | Verify | ||
| 2023-07-26 | Senator Dan Sullivan | Acquired Under $15K | Verify | ||
| 2023-05-11 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2023-05-10 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2023-05-01 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
| 2023-04-30 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
| 2022-12-21 | Senator Dan Sullivan | Acquired Under $15K | Verify | ||
| 2021-05-09 | Representative Richard W Allen | Acquired $15K to $50K | Verify | ||
| 2020-11-12 | Representative David B McKinley | Acquired Under $15K | Verify | ||
| 2016-10-05 | Senator John Reed | Acquired Under $15K | Verify | ||
| 2016-09-19 | Senator John Reed | Acquired Under $15K | Verify |
Thermo Fisher Outstanding Bonds
Thermo Fisher issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Thermo Fisher Scientific uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Thermo bonds can be classified according to their maturity, which is the date when Thermo Fisher Scientific has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| THERMO FISHER SCIENTIFIC Corp BondUS883556BG65 | View | |
| TMO 495 21 NOV 32 Corp BondUS883556CU41 | View | |
| TMO 48 21 NOV 27 Corp BondUS883556CT77 | View | |
| TMO 28 15 OCT 41 Corp BondUS883556CM25 | View | |
| THERMO FISHER SCIENTIFIC Corp BondUS883556BZ47 | View | |
| THERMO FISHER SCIENTIFIC Corp BondUS883556BY71 | View | |
| TMO 2 15 OCT 31 Corp BondUS883556CL42 | View | |
| TMO 175 15 OCT 28 Corp BondUS883556CK68 | View |
Thermo Fisher Corporate Filings
| 17th of June 2025 Other Reports | ViewVerify | |
F3 | 3rd of June 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
| 30th of May 2025 Other Reports | ViewVerify | |
8K | 28th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Pair Trading with Thermo Fisher
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Thermo Fisher position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thermo Fisher will appreciate offsetting losses from the drop in the long position's value.Moving together with Thermo Stock
Moving against Thermo Stock
| 0.8 | KG | KING PHARMACEUTICALS INC Symbol Change | PairCorr |
| 0.57 | EXEL | Exelixis | PairCorr |
| 0.53 | VTYX | Ventyx Biosciences | PairCorr |
| 0.42 | ACB | Aurora Cannabis | PairCorr |
| 0.37 | FBRX | Forte Biosciences | PairCorr |
The ability to find closely correlated positions to Thermo Fisher could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Thermo Fisher when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Thermo Fisher - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Thermo Fisher Scientific to buy it.
The correlation of Thermo Fisher is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Thermo Fisher moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Thermo Fisher Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Thermo Fisher can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.15 | Dividend Share 1.6 | Earnings Share 17.07 | Revenue Per Share | Quarterly Revenue Growth 0.002 |
The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.